Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: England
Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.
A former senior figure at England’s NICE states that advanced therapies for common conditions would not qualify for the usual payment modifiers.